Introduction: Drug–drug interactions (DDIs) arise in numerous different ways, involving
pharmacokinetic or pharmacodynamic mechanisms. Adverse drug reactions are a possible …

Problems associated with pharmacotherapy (in particular, medication errors and adverse
drug events) are frequent and are associated with increased costs for treatment. Analysis of …

Background: Potential drug–drug interactions (PDDIs) in patients with cancer are common,
but have not previously been quantified for oral anticancer treatment. We assessed the …

O artigo tem por objetivo refletir sobre a polifarmácia em idosos com ênfase nas reações
adversas e nas interações medicamentosas. A vulnerabilidade dos idosos aos problemas …

Purpose To evaluate the prevalence of drug-drug interactions (DDI) in hospitalized patients
and to identify associated risk factors. Methods A retrospective cross-sectional analysis of …

Background Cancer patients receive numerous medications, including antineoplastic
agents, drugs for supportive care, and medications for comorbid illnesses. Therefore, they …

Purpose Our objective was to evaluate the incidence of adverse patient outcomes due to
drug–drug interactions (D–DIs), the type of drugs involved and the underlying reason. As a …

Objective: To examine the nature and frequency of DRPs in community pharmacies among
patients discharged from hospitals in several countries, and to examine several variables …

Objectives To quantify the frequency of potential drug interactions unrelated to
chemotherapy in cancer patients admitted to our institution, and to define risk factors for such …

OBJECTIVES: To investigate the prevalence of potential drug interactions at the intensive
care unit of a university hospital in Brazil and to analyze their clinical significance …